DNABW (Ginkgo Bioworks Holdings) Current Deferred Revenue : $26.01 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Ginkgo Bioworks Holdings's current deferred revenue for the quarter that ended in Jun. 2024 was $26.01 Mil.

Ginkgo Bioworks Holdings Current Deferred Revenue Historical Data

The historical data trend for Ginkgo Bioworks Holdings's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings Current Deferred Revenue Chart

Ginkgo Bioworks Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Revenue

28.82

33.24

47.82

48.50

Ginkgo Bioworks Holdings Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Current Deferred Revenue	Get a 7-Day Free Trial												39.22	42.76	48.50	33.61	26.01

Ginkgo Bioworks Holdings Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Ginkgo Bioworks Holdings's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Ginkgo Bioworks Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (OTCPK:DNABW) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

DNA:USA DNA:Mexico

Address

27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210

Website

https://www.ginkgobioworks.com

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.